{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:41:33Z","timestamp":1777675293553,"version":"3.51.4"},"reference-count":86,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,23]],"date-time":"2026-12-23T00:00:00Z","timestamp":1797984000000},"content-version":"am","delay-in-days":387,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA023168"],"award-info":[{"award-number":["P30 CA023168"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA258737"],"award-info":[{"award-number":["R01 CA258737"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA232419"],"award-info":[{"award-number":["R01 CA232419"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.xphs.2025.104065","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T05:47:26Z","timestamp":1763185646000},"page":"104065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Phosphatidylserine blockade by dipicolylamine-zinc enhances chemoimmunotherapy of B16F10 melanoma"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7141-3473","authenticated-orcid":false,"given":"Jianping","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4231-7888","authenticated-orcid":false,"given":"Fanfei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6577-0244","authenticated-orcid":false,"given":"Ziang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3934-5922","authenticated-orcid":false,"given":"Yanying","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1203-6398","authenticated-orcid":false,"given":"Karen Gutierrez","family":"Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2008-5618","authenticated-orcid":false,"given":"Kunyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor G.","family":"Sargent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9505-7701","authenticated-orcid":false,"given":"Yoon","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6330","key":"10.1016\/j.xphs.2025.104065_bib0001","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.355.6330.1220","article-title":"Cancer immunotherapy comes of age","volume":"355","author":"Dance","year":"2017","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.xphs.2025.104065_bib0002","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.3390\/cancers3043856","article-title":"Cytokines in cancer immunotherapy","volume":"3","author":"Lee","year":"2011","journal-title":"Cancers"},{"key":"10.1016\/j.xphs.2025.104065_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2024.103105","article-title":"Delivery of STING agonists for cancer immunotherapy","volume":"87","author":"Wang","year":"2024","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"10.1016\/j.xphs.2025.104065_bib0004","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41392-023-01522-4","article-title":"Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.xphs.2025.104065_bib0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13045-021-01164-5","article-title":"Combination strategies to maximize the benefits of cancer immunotherapy","volume":"14","author":"Zhu","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"46","key":"10.1016\/j.xphs.2025.104065_bib0006","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1038\/onc.2016.104","article-title":"Damage-associated molecular patterns in cancer: a double-edged sword","volume":"35","author":"Hernandez","year":"2016","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.xphs.2025.104065_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15112912","article-title":"Chemo-immunotherapy: a new trend in cancer treatment","volume":"15","author":"Sordo-Bahamonde","year":"2023","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.xphs.2025.104065_bib0008","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr Biol"},{"issue":"1","key":"10.1016\/j.xphs.2025.104065_bib0009","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun Signal"},{"issue":"18","key":"10.1016\/j.xphs.2025.104065_bib0010","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.xphs.2025.104065_bib0011","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fimmu.2015.00202","article-title":"Therapeutic potential and challenges of natural killer cells in treatment of solid tumors","volume":"6","author":"Gras Navarro","year":"2015","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.xphs.2025.104065_bib0012","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.xphs.2025.104065_bib0013","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.xphs.2025.104065_bib0014","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/s41467-022-33598-x","article-title":"Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer","volume":"13","author":"Monteran","year":"2022","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.xphs.2025.104065_bib0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41565-022-01266-2","article-title":"Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy","volume":"18","author":"Chen","year":"2023","journal-title":"Nat Nanotechnol"},{"issue":"5","key":"10.1016\/j.xphs.2025.104065_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111582","article-title":"Mobilizing phospholipids on tumor plasma membrane implicates phosphatidylserine externalization blockade for cancer immunotherapy","volume":"41","author":"Wang","year":"2022","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.xphs.2025.104065_bib0017","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S0006-3495(03)74596-2","article-title":"Curvature and bending constants for phosphatidylserine-containing membranes","volume":"85","author":"Fuller","year":"2003","journal-title":"Biophys J"},{"key":"10.1016\/j.xphs.2025.104065_bib0018","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev.biophys.093008.131234","article-title":"The distribution and function of phosphatidylserine in cellular membranes","volume":"39","author":"Leventis","year":"2010","journal-title":"Annu Rev Biophys"},{"key":"10.1016\/j.xphs.2025.104065_bib0019","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-94-007-6331-9_10","article-title":"Phosphatidylserine-mediated cellular signaling","volume":"991","author":"Kay","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.xphs.2025.104065_bib0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fimmu.2011.00057","article-title":"Modulation of macrophage efferocytosis in inflammation","volume":"2","author":"Korns","year":"2011","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.xphs.2025.104065_bib0021","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1038\/emm.2017.52","article-title":"Engulfment signals and the phagocytic machinery for apoptotic cell clearance","volume":"49","author":"Park","year":"2017","journal-title":"Exp Mol Med"},{"issue":"2","key":"10.1016\/j.xphs.2025.104065_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108620","article-title":"Targeting phosphatidylserine enhances the anti-tumor response to tumor-directed radiation therapy in a preclinical model of melanoma","volume":"34","author":"Budhu","year":"2021","journal-title":"Cell Rep"},{"issue":"6515","key":"10.1016\/j.xphs.2025.104065_bib0023","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/373623a0","article-title":"Axl receptor tyrosine kinase stimulated by the vitamin-K-dependent protein encoded by growth-arrest-specific gene-6","volume":"373","author":"Varnum","year":"1995","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.xphs.2025.104065_bib0024","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0092-8674(95)90520-0","article-title":"The anticoagulation factor protein-S and its relative, Gas6, are ligands for the tyro 3\/Axl family of receptor tyrosine kinases","volume":"80","author":"Stitt","year":"1995","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.xphs.2025.104065_bib0025","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.immuni.2007.11.011","article-title":"TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells","volume":"27","author":"Kobayashi","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.xphs.2025.104065_bib0026","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.0105-2896.2010.00903.x","article-title":"TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity","volume":"235","author":"Freeman","year":"2010","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.xphs.2025.104065_bib0027","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/cdd.2016.11","article-title":"Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer","volume":"23","author":"Birge","year":"2016","journal-title":"Cell Death Differ"},{"issue":"6","key":"10.1016\/j.xphs.2025.104065_bib0028","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.4049\/jimmunol.162.6.3498","article-title":"A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock","volume":"162","author":"Camenisch","year":"1999","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.xphs.2025.104065_bib0029","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1074\/jbc.M706906200","article-title":"Autophosphorylation docking site Tyr-867 in Mer receptor tyrosine kinase allows for dissociation of multiple signaling pathways for phagocytosis of apoptotic cells and down-modulation of lipopolysaccharide-inducible NF-kappaB transcriptional activation","volume":"283","author":"Tibrewal","year":"2008","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.xphs.2025.104065_bib0030","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1182\/blood-2006-04-017368","article-title":"Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells","volume":"109","author":"Sen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.xphs.2025.104065_bib0031","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.omtn.2017.10.019","article-title":"A novel therapeutic strategy for cancer using phosphatidylserine targeting stearylamine-bearing cationic liposomes","volume":"10","author":"De","year":"2018","journal-title":"Mol Ther-Nucl Acids"},{"issue":"11","key":"10.1016\/j.xphs.2025.104065_bib0032","first-page":"3062","article-title":"Elevated expression of phosphatidylserine in the outer-membrane leaflet of human tumor-cells and recognition by activated human blood monocytes","volume":"51","author":"Utsugi","year":"1991","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.xphs.2025.104065_bib0033","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.bbamem.2011.07.026","article-title":"In search of a novel target - phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy","volume":"1808","author":"Riedl","year":"2011","journal-title":"Bba-Biomembranes"},{"issue":"21","key":"10.1016\/j.xphs.2025.104065_bib0034","first-page":"6132","article-title":"Increased exposure of anionic phospholipids on the surface of tumor blood vessels","volume":"62","author":"Ran","year":"2002","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.xphs.2025.104065_bib0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2009.03.041","article-title":"Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner","volume":"283","author":"Lima","year":"2009","journal-title":"Cancer Lett"},{"issue":"7","key":"10.1016\/j.xphs.2025.104065_bib0036","first-page":"1302","article-title":"Molecular lipidomics of exosomes released by PC-3 prostate cancer cells","volume":"1831","author":"Llorente","year":"2013","journal-title":"Bba-Mol Cell Biol L"},{"issue":"17","key":"10.1016\/j.xphs.2025.104065_bib0037","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1158\/1078-0432.CCR-07-0793","article-title":"Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids","volume":"13","author":"He","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.xphs.2025.104065_bib0038","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jconrel.2014.03.043","article-title":"Phosphatidylserine-targeted bimodal liposomal nanoparticles for in vivo imaging of breast cancer in mice","volume":"183","author":"Zhang","year":"2014","journal-title":"J Control Release"},{"issue":"6","key":"10.1016\/j.xphs.2025.104065_bib0039","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1593\/tlo.11178","article-title":"Near-infrared optical imaging of exposed phosphatidylserine in a Mouse Glioma model","volume":"4","author":"Zhao","year":"2011","journal-title":"Transl Oncol"},{"issue":"22","key":"10.1016\/j.xphs.2025.104065_bib0040","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1158\/1078-0432.CCR-09-1499","article-title":"Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma","volume":"15","author":"He","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.xphs.2025.104065_bib0041","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/jcp.22815","article-title":"Eat-me signals: keys to molecular phagocyte biology and \"appetite\" control","volume":"227","author":"Li","year":"2012","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.xphs.2025.104065_bib0042","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.629979","article-title":"The phagocytic code regulating phagocytosis of mammalian cells","volume":"12","author":"Cockram","year":"2021","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.xphs.2025.104065_bib0043","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1167\/iovs.13-13346","article-title":"Bis(zinc-dipicolylamine), Zn-DPA, a new marker for apoptosis","volume":"55","author":"Kwong","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xphs.2025.104065_bib0044","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10.1016\/j.xphs.2025.104065_bib0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0305-7372(82)80014-5","article-title":"Doxorubicin cardiotoxicity","volume":"9","author":"Unverferth","year":"1982","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"10.1016\/j.xphs.2025.104065_bib0046","doi-asserted-by":"crossref","first-page":"H1091","DOI":"10.1152\/ajpheart.00290.2018","article-title":"Doxorubicin triggers splenic contraction and irreversible dysregulation of COX and LOX that alters the inflammation-resolution program in the myocardium","volume":"315","author":"Jadapalli","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"10.1016\/j.xphs.2025.104065_bib0047","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/jat.4666","article-title":"Possible pathogenic mechanisms for doxorubicin-induced splenic atrophy in a human breast cancer xenograft mouse model","volume":"44","author":"Xue","year":"2024","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.xphs.2025.104065_bib0048","article-title":"A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity","volume":"1","author":"Tian","year":"2016","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"10.1016\/j.xphs.2025.104065_bib0049","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0039-6060(96)80166-8","article-title":"Granulocyte-macrophage colony-stimulating factor inhibits tumor growth during the postoperative period","volume":"119","author":"Hill","year":"1996","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.xphs.2025.104065_bib0050","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/cmi.2017.105","article-title":"Revisiting GM-CSF as an adjuvant for therapeutic vaccines","volume":"15","author":"Zhao","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.xphs.2025.104065_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.901277","article-title":"GM-CSF: a double-edged sword in cancer immunotherapy","volume":"13","author":"Kumar","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.xphs.2025.104065_bib0052","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2217\/imt-2016-0141","article-title":"Recent progress in GM-CSF-based cancer immunotherapy","volume":"9","author":"Yan","year":"2017","journal-title":"Immunotherapy"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2025.104065_bib0053","article-title":"Liposomal delivery enhances immune activation by STING agonists for cancer immunotherapy","volume":"1","author":"Koshy","year":"2017","journal-title":"Adv Biosyst"},{"issue":"11","key":"10.1016\/j.xphs.2025.104065_bib0054","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41565-021-00962-9","article-title":"Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy","volume":"16","author":"Sun","year":"2021","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"10.1016\/j.xphs.2025.104065_bib0055","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s42003-021-02004-5","article-title":"ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance","volume":"4","author":"Jang","year":"2021","journal-title":"Commun Biol"},{"issue":"5","key":"10.1016\/j.xphs.2025.104065_bib0056","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41551-020-00675-9","article-title":"Prolonged activation of innate immune pathways by a polyvalent STING agonist","volume":"5","author":"Li","year":"2021","journal-title":"Nat Biomed Eng"},{"issue":"11","key":"10.1016\/j.xphs.2025.104065_bib0057","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1016\/j.celrep.2018.11.047","article-title":"Magnitude of therapeutic STING activation determines CD8(+) T cell-mediated anti-tumor immunity","volume":"25","author":"Sivick","year":"2018","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.xphs.2025.104065_bib0058","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12964-020-0521-5","article-title":"TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy","volume":"18","author":"Dayoub","year":"2020","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.xphs.2025.104065_bib0059","unstructured":"The human protein atlas. Available at: https:\/\/www.proteinatlas.org\/ENSG00000091583-APOH\/cancer."},{"key":"10.1016\/j.xphs.2025.104065_bib0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12967-016-0843-7","article-title":"Annexins family: insights into their functions and potential role in pathogenesis of sarcoidosis","volume":"14","author":"Mirsaeidi","year":"2016","journal-title":"J Transl Med"},{"issue":"9","key":"10.1016\/j.xphs.2025.104065_bib0061","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1084\/jem.20040327","article-title":"Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo","volume":"200","author":"Bondanza","year":"2004","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.xphs.2025.104065_bib0062","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s41467-020-14821-z","article-title":"Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment","volume":"11","author":"Kang","year":"2020","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.xphs.2025.104065_bib0063","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1016\/j.bmc.2011.04.029","article-title":"Synthesis and preliminary evaluation of radiolabeled bis(zinc(II)-dipicolylamine) coordination complexes as cell death imaging agents","volume":"19","author":"Wyffels","year":"2011","journal-title":"Bioorg Med Chem"},{"issue":"10","key":"10.1016\/j.xphs.2025.104065_bib0064","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1021\/cr900134a","article-title":"Application of metal coordination chemistry to explore and manipulate cell biology","volume":"109","author":"Haas","year":"2009","journal-title":"Chem Rev"},{"issue":"10","key":"10.1016\/j.xphs.2025.104065_bib0065","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003148","article-title":"Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments","volume":"9","author":"Bhatta","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.xphs.2025.104065_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100897","article-title":"BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy","volume":"14","author":"Chen","year":"2021","journal-title":"Transl Oncol"},{"key":"10.1016\/j.xphs.2025.104065_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.155596","article-title":"DPA-Zn enables targeting and bypassing endosomal trapping delivery of a genome-editing system into cancer cells via phosphatidylserine-mediated endocytic pathway","volume":"498","author":"Shao","year":"2024","journal-title":"Chem Eng J"},{"key":"10.1016\/j.xphs.2025.104065_bib0068","series-title":"Method For Detecting Phosphatidylserine on the Surface of Cells","author":"Smith","year":"2003"},{"issue":"4","key":"10.1016\/j.xphs.2025.104065_bib0069","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/bc500003x","article-title":"Library synthesis, screening, and discovery of modified Zinc(II)-Bis(dipicolylamine) probe for enhanced molecular imaging of cell death","volume":"25","author":"Plaunt","year":"2014","journal-title":"Bioconjug Chem"},{"issue":"10","key":"10.1016\/j.xphs.2025.104065_bib0070","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1002\/anie.201812489","article-title":"A fluorogenic probe for cell surface phosphatidylserine using an intramolecular indicator displacement sensing mechanism","volume":"58","author":"Zwicker","year":"2019","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.xphs.2025.104065_bib0071","article-title":"PSVue\u00ae: novel small molecule probes for fluorescent imaging of apoptosis and bacterial infections in vitro and in vivo","author":"Gray","year":"2011","journal-title":"Nat Methods Appl Notes"},{"issue":"11","key":"10.1016\/j.xphs.2025.104065_bib0072","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1158\/2326-6066.CIR-15-0086","article-title":"Extracellular vesicles present in human ovarian tumor microenvironments induce a phosphatidylserine-dependent arrest in the T-cell signaling cascade","volume":"3","author":"Kelleher","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.xphs.2025.104065_bib0073","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1034\/j.1600-065X.2002.18813.x","article-title":"GM-CSF-based cancer vaccines","volume":"188","author":"Dranoff","year":"2002","journal-title":"Immunol Rev"},{"issue":"5","key":"10.1016\/j.xphs.2025.104065_bib0074","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"Kantoff","year":"2010","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.xphs.2025.104065_bib0075","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1182\/blood-2011-11-370130","article-title":"Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy","volume":"119","author":"van de Laar","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.xphs.2025.104065_bib0076","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1189\/jlb.3RU0316-144R","article-title":"Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage","volume":"100","author":"Ushach","year":"2016","journal-title":"J Leukoc Biol"},{"issue":"5","key":"10.1016\/j.xphs.2025.104065_bib0077","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.cell.2013.08.014","article-title":"Cyclic dinucleotides and the innate immune response","volume":"154","author":"Danilchanka","year":"2013","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.xphs.2025.104065_bib0078","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112695","article-title":"STING agonists as cancer therapeutics","volume":"13","author":"Amouzegar","year":"2021","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.xphs.2025.104065_bib0079","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9080917","article-title":"The promise and challenges of cyclic dinucleotides as molecular adjuvants for vaccine development","volume":"9","author":"Yan","year":"2021","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.xphs.2025.104065_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095728","article-title":"The mucosal adjuvant cyclic di-AMP exerts immune stimulatory effects on dendritic cells and macrophages","volume":"9","author":"Skrnjug","year":"2014","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.xphs.2025.104065_bib0081","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","article-title":"Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced\/metastatic solid tumors or lymphomas","volume":"28","author":"Meric-Bernstam","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"6431","key":"10.1016\/j.xphs.2025.104065_bib0082","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8657","article-title":"cGAS in action: expanding roles in immunity and inflammation","volume":"363","author":"Ablasser","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.xphs.2025.104065_bib0083","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jconrel.2020.11.017","article-title":"Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration","volume":"330","author":"Wehbe","year":"2021","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.xphs.2025.104065_bib0084","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41565-018-0342-5","article-title":"Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy","volume":"14","author":"Shae","year":"2019","journal-title":"Nat Nanotechnol"},{"issue":"10","key":"10.1016\/j.xphs.2025.104065_bib0085","doi-asserted-by":"crossref","DOI":"10.3390\/mi13101623","article-title":"Sustained drug release from smart nanoparticles in cancer therapy: a comprehensive review","volume":"13","author":"Bai","year":"2022","journal-title":"Micromachines"},{"issue":"3","key":"10.1016\/j.xphs.2025.104065_bib0086","first-page":"1082","article-title":"Skin irritation study of intradermal patch of chitosan containing trazodone-HCl on rat skin","volume":"2","author":"Jain","year":"2011","journal-title":"Int J Res Pharm Biomed Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925005192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925005192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:24:59Z","timestamp":1773912299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925005192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":86,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0022354925005192"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.104065","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphatidylserine blockade by dipicolylamine-zinc enhances chemoimmunotherapy of B16F10 melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.104065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104065"}}